Literature DB >> 2547990

Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes.

Y Sakai1, H Shibuta.   

Abstract

The highly syncytium-inducing M strain and the weakly syncytium-inducing SC strain of bovine parainfluenza 3 virus differ by a single amino acid substitution in each of the hemagglutinin-neuraminidase (HN) and membrane (M) proteins, while their fusion (F) proteins are identical (T. Shioda, S. Wakao, S. Suzu, and H. Shibuta, Virology 162:388-396, 1988). We constructed recombinant vaccinia viruses which express separately the M virus HN (Vac-MHN), SC virus HN (Vac-SCHN), M virus M (Vac-MM), SC virus M (Vac-SCM), and common F (Vac-F) proteins. CV-1 cells were infected with the recombinants, singly or in combination, and implanted onto indicator MDBK cells for syncytium formation. Combinations of Vac-MHN plus Vac-F and Vac-SCHN plus Vac-F induced extensive and weak syncytium formation, respectively. Vac-F alone did not induce syncytium formation, and both Vac-MM and Vac-SCM had no effect on syncytium formation. These findings indicated that the syncytium formation by bovine parainfluenza 3 virus requires both the F and HN proteins and that the extensive syncytium formation by the M virus is due to the M virus HN protein. MSC, another weakly syncytium-inducing virus variant, newly isolated from the M virus, was identical to the M virus in the primary structure of the HN and M proteins but differed from the M virus by a single amino acid residue in the F protein. The combination of the recombinant vaccinia virus expressing the MSC virus F protein and Vac-MHN resulted in weak syncytium formation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547990      PMCID: PMC250956          DOI: 10.1128/JVI.63.9.3661-3668.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus.

Authors:  H Shibuta; A Adachi; T Kanda; M Matumoto
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

2.  High-efficiency cloning of full-length cDNA.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

3.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity.

Authors:  D C Merz; J S Wolinsky
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

6.  Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene.

Authors:  S Venkatesan; B M Baroudy; B Moss
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

7.  Experimental parainfluenza virus infection in mice: growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain.

Authors:  H Shibuta; T Kanda; A Nozawa; S Sato; T Kumanishi
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein.

Authors:  D C Merz; J S Wolinsky
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

10.  Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus.

Authors:  H Shibuta; A Nozawa; T Shioda; T Kanda
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  21 in total

1.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Analysis of the fusion protein gene of the porcine rubulavirus LPMV: comparative analysis of paramyxovirus F proteins.

Authors:  M Berg; A C Bergvall; M Svenda; A Sundqvist; J Moreno-López; T Linné
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Transfection of Sendai virus F gene cDNA with mutations at its cleavage site and HN gene cDNA into COS cells induces cell fusion.

Authors:  H Taira; T Sato; H Segawa; M Chiba; T Katsumata; K Iwasaki
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Identification of an amino acid that defines the fusogenicity of mumps virus.

Authors:  K Tanabayashi; K Takeuchi; K Okazaki; M Hishiyama; A Yamada
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

5.  Hemagglutinin-neuraminidase enhances F protein-mediated membrane fusion of reconstituted Sendai virus envelopes with cells.

Authors:  S Bagai; A Puri; R Blumenthal; D P Sarkar
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Fusion regulation proteins on the cell surface: isolation and characterization of monoclonal antibodies which enhance giant polykaryocyte formation in Newcastle disease virus-infected cell lines of human origin.

Authors:  Y Ito; H Komada; S Kusagawa; M Tsurudome; H Matsumura; M Kawano; H Ohta; M Nishio
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector.

Authors:  Lingshu Wang; Sreekumar Menon; Steven R Bolin; Leonard J Bello
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase.

Authors:  R M Iorio; R L Glickman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion.

Authors:  A Moscona; R W Peluso
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.